Avadel Pharmaceutics’ $125 Million follow-on Equity Offering

Goodwin Procter advised Avadel Pharmaceutics plc on the deal.Avadel Pharmaceuticals announced an underwritten public offering of 10,000,001 of its ordinary shares, nominal value $0.01 per share…